Although upregulation of expression level of the key glycolytic enzyme HK2 gene and glucose transporter 3 was found in brain metastases (Palmieri et al., 2009; Kuo et al., 2019), increased glycolytic activity does not appear to be a metabolic feature of brain metastases from breast cancer. The gene discussed is HK1; the disease is breast carcinoma.